Bromodomain Extraterminal (BET) Family Inhibitor JQ1 Inhibits Nuclear Maturation and Cytoplasmic Organization of Oocytes.

被引：0
|
作者：
Poojary, Keerthana Karunakar [1 ]
Kumari, Sandhya [1 ]
Adiga, Satish K. [1 ]
Kalthur, Guruprasad [1 ]
机构：
[1] Kasturba Med Coll & Hosp, Udupi, India
来源：
REPRODUCTIVE SCIENCES | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-051
引用
收藏
页码：68A / 68A
页数：1
相关论文
共 50 条
  • [21] The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
    Garcia, P. L.
    Miller, A. L.
    Kreitzburg, K. M.
    Council, L. N.
    Gamblin, T. L.
    Christein, J. D.
    Heslin, M. J.
    Arnoletti, J. P.
    Richardson, J. H.
    Chen, D.
    Hanna, C. A.
    Cramer, S. L.
    Yang, E. S.
    Qi, J.
    Bradner, J. E.
    Yoon, K. J.
    ONCOGENE, 2016, 35 (07) : 833 - 845
  • [22] MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells
    Kato, Fuyumi
    Fiorentino, Francesco Paolo
    Alibes, Andreu
    Perucho, Manuel
    Sanchez-Cespedes, Montse
    Kohno, Takashi
    Yokota, Jun
    ONCOTARGET, 2016, 7 (47) : 77378 - 77388
  • [23] Selective BET bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T cell responses
    Remke, N.
    Bisht, S.
    Nolting, J.
    Brossart, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 73 - 73
  • [24] BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells
    Saeed Alghamdi
    Irfan Khan
    Naimisha Beeravolu
    Christina McKee
    Bryan Thibodeau
    George Wilson
    G. Rasul Chaudhry
    Stem Cell Research & Therapy, 7
  • [25] The BET bromodomain inhibitor JQ1 suppresses cancer cell growth in naive and sunitinib resistant renal cell carcinoma
    Sakaguchi, Takashi
    Yoshino, Hirofumi
    Sugita, Satoshi
    Osako, Youichi
    Yonemori, Masaya
    Miyamoto, Kazutaka
    Enokida, Hideki
    Nakagawa, Masayuki
    CANCER SCIENCE, 2018, 109 : 336 - 336
  • [26] BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells
    Alghamdi, Saeed
    Khan, Irfan
    Beeravolu, Naimisha
    McKee, Christina
    Thibodeau, Bryan
    Wilson, George
    Chaudhry, G. Rasul
    STEM CELL RESEARCH & THERAPY, 2016, 7
  • [27] Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice
    Kedaigle, Amanda J.
    Reidling, Jack C.
    Lim, Ryan G.
    Adam, Miriam
    Wu, Jie
    Wassie, Brook
    Stocksdale, Jennifer T.
    Casale, Malcolm S.
    Fraenkel, Ernest
    Thompson, Leslie M.
    HUMAN MOLECULAR GENETICS, 2020, 29 (02) : 202 - 215
  • [28] Development of resistance to BET bromodomain inhibitor JQ1 and demonstration in epithelial-mesenchymal transition in pancreatic cancer cells.
    Raza, Sania S.
    Knab, Mark
    Chow, Christina
    Kumar, Krishan
    Ebine, Kazumi
    Munshi, Hidayatullah G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses
    Remke, Niklas
    Bisht, Savita
    Oberbeck, Sebastian
    Nolting, Jens
    Brossart, Peter
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (01) : 107 - 121
  • [30] The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
    Li, Zichong
    Guo, Jia
    Wu, Yuntao
    Zhou, Qiang
    NUCLEIC ACIDS RESEARCH, 2013, 41 (01) : 277 - 287
12345